Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon files a lawsuit against the developer of a burnt-out warehouse in Istra

2/10/25 OZON

VK Video's revenue from native advertising in doubled

2/10/25 VKCO

LSR sold 4.7 hectares on Perevoznaya Street in St. Petersburg

2/10/25 LSRG

Trading volume on SPB Exchange over the weekend increased 1.86 times

2/10/25 SPBE

Kamaz took 27% of the market of heavy trucks

2/10/25 KMAZ

Europlan's new business volume decreased by 0.3% in 2024

2/10/25 LEAS

Sberbank closes Drive Click Bank

2/10/25 SBER

UAC reports for 2024 by RAS

2/7/25 UNAC

Kamaz reported for 2024 by RAS

2/7/25 KMAZ

Positive Technologies shipments in 2024 came in well below management's plans

2/7/25 POSI